• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

Introduction to 7-Chloro-3H-Imidazo[4,5-b]pyridin-5-amine (CAS No. 37436-96-7)

7-Chloro-3H-Imidazo[4,5-b]pyridin-5-amine, also known by its CAS number 37436-96-7, is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of imidazopyridines, which are known for their diverse biological activities, including antiviral, antibacterial, and antitumor properties. The structure of 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine consists of a pyridine ring fused with an imidazole ring, with a chlorine substituent at the 7-position and an amino group at the 5-position. This unique molecular architecture contributes to its potential therapeutic applications and makes it an important molecule for further investigation.

The synthesis of 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine has been extensively studied in recent years. One common synthetic route involves the cyclization of a suitable precursor, such as a substituted pyridine or imidazole derivative, followed by functional group modifications to introduce the chlorine and amino groups. The choice of starting materials and reaction conditions can significantly influence the yield and purity of the final product. Advanced techniques such as microwave-assisted synthesis and catalytic methods have also been explored to optimize the synthesis process.

In terms of its biological activity, 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine has shown promising results in various preclinical studies. Research has demonstrated its potential as an antiviral agent, particularly against RNA viruses such as influenza and hepatitis C. The compound's ability to inhibit viral replication is attributed to its interaction with specific viral enzymes or host cell factors. Additionally, studies have indicated that 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine possesses antibacterial properties, making it a candidate for the development of novel antibiotics. Its activity against both Gram-positive and Gram-negative bacteria has been reported, highlighting its broad-spectrum potential.

The antitumor properties of 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine have also been investigated. Preclinical studies have shown that this compound can induce apoptosis in cancer cells through multiple mechanisms, including the modulation of cell cycle progression and the activation of pro-apoptotic signaling pathways. These findings suggest that 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine could be a valuable lead compound for the development of new anticancer drugs.

Beyond its direct therapeutic applications, 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine serves as a useful scaffold for medicinal chemistry efforts. The flexibility of its structure allows for the introduction of various functional groups to enhance or modify its biological activity. For example, substituents at different positions on the imidazopyridine ring can be systematically varied to explore structure–activity relationships (SARs). This approach has led to the identification of several analogs with improved potency and selectivity.

The pharmacokinetic properties of 7-chloro-3H-Imidazo[4,5-b]pyridin-5-amine are another important aspect of its evaluation. Studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles in preclinical models. Its oral bioavailability and plasma stability are key factors that contribute to its potential as a drug candidate. However, further research is needed to optimize these properties for clinical use.

In conclusion, 7-chloro-3H-imidazo[4,5-b]pyridin-5-amine (CAS No. 37436-96-7) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and diverse biological activities make it an attractive target for further investigation and development. As ongoing research continues to uncover new insights into its mechanisms of action and therapeutic potential, this compound is likely to play an increasingly important role in advancing our understanding and treatment of various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)